[{"Assets_0_Q1_USD":69342000000.0,"CommonStockDividendsPerShareDeclared_1_Q1_USD":0.96,"CommonStockSharesConverted_0_Q1_shares":1775505540.0,"EarningsPerShareBasic_1_Q1_USD":1.74,"EarningsPerShareDiluted_1_Q1_USD":1.74,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":2645000000.0,"NetIncomeLossConverted_1_Q1_USD":2771000000.0,"RevenuesConverted_1_Q1_USD":7934000000.0,"StockholdersEquity_0_Q1_USD":3553000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":1596000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":1591000000.0,"Ticker":"ABBV","CIK":"1551152","name":"ABBVIE INC.","OfficialName":"AbbVie Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"276159000000.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20180504"}]